Wealth Preservation Advisors’s Sanara MedTech SMTI Stock Holding History

Wealth Preservation Advisors’s Portfolio SMTI Stock Details SMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$86	Buy	+5	New	+$103	﹤0.01%	945

Other funds holding SMTI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SWM

Stonebridge Wealth Management Oak Brook, Illinois $112M AUM 23.07% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Wealth Preservation Advisors's SMTI Position: Q1 2026 in Review

Wealth Preservation Advisors opened a new position in Sanara MedTech (SMTI) in Q1 2026: 5 shares worth $86. The stake represents ﹤0.01% of the portfolio and ranks #945 among its holdings.

65 funds tracked by Wall St. Rank hold SMTI as of Q1 2026.

Wealth Preservation Advisors held 5 shares of Sanara MedTech worth $86 as of Q1 2026.
Sanara MedTech was a new Wealth Preservation Advisors position in Q1 2026.
Sanara MedTech made up ﹤0.01% of Wealth Preservation Advisors's portfolio in Q1 2026, its #945 holding.
65 funds tracked by Wall St. Rank held Sanara MedTech as of Q1 2026.

Based on Wealth Preservation Advisors's 13F filing for Q1 2026, filed 15 May 2026.